NO20054319L - Neovaskulaseringspromoter - Google Patents

Neovaskulaseringspromoter

Info

Publication number
NO20054319L
NO20054319L NO20054319A NO20054319A NO20054319L NO 20054319 L NO20054319 L NO 20054319L NO 20054319 A NO20054319 A NO 20054319A NO 20054319 A NO20054319 A NO 20054319A NO 20054319 L NO20054319 L NO 20054319L
Authority
NO
Norway
Prior art keywords
neovaskulaseringspromoter
neovascularization
pharmaceutically acceptable
acceptable salt
active ingredient
Prior art date
Application number
NO20054319A
Other languages
English (en)
Other versions
NO20054319D0 (no
Inventor
Mitsuhiro Kawada
Yukiko Inamoto
Ikuko Tsukamoto
Yasue Kubota
Original Assignee
Teikoku Seiyaku Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teikoku Seiyaku Kk filed Critical Teikoku Seiyaku Kk
Publication of NO20054319D0 publication Critical patent/NO20054319D0/no
Publication of NO20054319L publication Critical patent/NO20054319L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

En neovaskulariseringspromoter inneholdende acetylsalisylsyre eller et farmasøytisk akseptabelt salt av denne som en aktiv ingrediens.
NO20054319A 2003-02-21 2005-09-20 Neovaskulaseringspromoter NO20054319L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003044392A JP2004262776A (ja) 2003-02-21 2003-02-21 血管新生促進剤
PCT/JP2004/001700 WO2004073717A1 (ja) 2003-02-21 2004-02-17 血管新生促進剤

Publications (2)

Publication Number Publication Date
NO20054319D0 NO20054319D0 (no) 2005-09-20
NO20054319L true NO20054319L (no) 2005-11-18

Family

ID=32905451

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20054319A NO20054319L (no) 2003-02-21 2005-09-20 Neovaskulaseringspromoter

Country Status (11)

Country Link
US (1) US20060252732A1 (no)
EP (1) EP1595545A4 (no)
JP (1) JP2004262776A (no)
KR (1) KR20050102664A (no)
CN (1) CN1750832A (no)
AU (1) AU2004212812A1 (no)
CA (1) CA2515251A1 (no)
MX (1) MXPA05008884A (no)
NO (1) NO20054319L (no)
TW (1) TW200418493A (no)
WO (1) WO2004073717A1 (no)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2999936B1 (fr) * 2012-12-21 2015-01-16 Urgo Lab Utilisation d'acide acetylsalicylique pour la prevention et/ou le traitement des plaies du diabetique

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2307522A1 (fr) * 1975-04-17 1976-11-12 Rouillon Marie Claude Nouvelles compositions calmantes
EP0318488A4 (en) * 1986-08-18 1990-02-26 Biota Scient Management STIMULATION OF ANGIOGENESIS AND PROMOTION OF ENDOTHELIALIZATION.
WO1996018298A1 (en) * 1994-12-14 1996-06-20 Brinton Marshall K Method of treating poultry
NZ286082A (en) * 1995-03-15 1998-09-24 Behringwerke Ag Method of treating acute myocardial infarction with hirudin and acetylsalicylic acid in patients not undergoing thrombolytic treatment
DE69635298T2 (de) * 1995-12-26 2006-07-13 Teikoku Seiyaku K.K. Verwendung von Acetylsalicylsäuren zur Herstellung eines Medikaments für die Behandlung von Hautverletzungen
JPH09255575A (ja) * 1996-03-21 1997-09-30 Green Cross Corp:The アセチルサリチル酸誘導体含有製剤
JPH1112177A (ja) * 1997-06-25 1999-01-19 Teikoku Seiyaku Co Ltd 安定なアスピリン含有外用製剤
DE19949252B4 (de) * 1999-10-13 2004-02-12 Lts Lohmann Therapie-Systeme Ag Verwendung eines superfiziellen therapeutischen Systems zur topischen Applikation von Acetylsalicylsäure zur Behandlung von Akne-Erkrankungen und Verfahren zu seiner Herstellung
US20030125308A1 (en) * 1999-12-28 2003-07-03 Yukiko Inamoto Antipruritic agents for external use
JP2001187739A (ja) * 1999-12-28 2001-07-10 Teikoku Seiyaku Co Ltd アレルギー性皮膚疾患治療用外用剤
ITMI20000261A1 (it) * 2000-02-16 2001-08-16 Zambon Group Processo per la preparazione di piridiniliden-ftalidi
US20030232094A1 (en) * 2002-06-12 2003-12-18 Fuller Peter E. Composition and method for the treatment of skin irritations
WO2005077380A1 (ja) * 2004-02-16 2005-08-25 Teikoku Seiyaku Co., Ltd. 有痛性皮膚創傷の治療用外用剤
CA2555366A1 (en) * 2004-02-16 2005-08-25 Teikoku Seiyaku Co., Ltd. Remedy for external use for skin and mucosal injuries caused by viral infection

Also Published As

Publication number Publication date
US20060252732A1 (en) 2006-11-09
CN1750832A (zh) 2006-03-22
NO20054319D0 (no) 2005-09-20
EP1595545A1 (en) 2005-11-16
TW200418493A (en) 2004-10-01
JP2004262776A (ja) 2004-09-24
CA2515251A1 (en) 2004-09-02
AU2004212812A1 (en) 2004-09-02
KR20050102664A (ko) 2005-10-26
EP1595545A4 (en) 2006-03-22
WO2004073717A1 (ja) 2004-09-02
MXPA05008884A (es) 2005-10-05

Similar Documents

Publication Publication Date Title
NO20080220L (no) Formuleringer med hoy medikament belastning og doseringsformer
SV2004001690A (es) Nuevos derivados de fluoroglicosidos heterociclicos, medicamentos que contienen estos compuestos, y el uso de los mismos
NO20052739D0 (no) CCR5-antagonister som medikamenter
HN2004000544A (es) Nuevos derivados de quinolinas
NO20053076D0 (no) Farmasoytisk formulering med en uloselig aktiv forbindelse.
DE602005027540D1 (de) Feste formulierungen von ospemifen
NO20075660L (no) Blanding for behandling av inflammatoriske sykdommer
NO20050060L (no) Medikament for behandling av overaktiv blaere
ECSP055701A (es) Nuevos derivados de pirimidinamida y el uso de los mismos
EA201201202A1 (ru) Пероральная фармацевтическая композиция, содержащая этексилат дабигатрана
CY1110097T1 (el) Διπλοστοιβαδικο δισκιο για προληψη καρδιαγγειακων συμβαντων
ATE537822T1 (de) Antidepressivum
NO20082181L (no) Formuleringer av Fispemifen
BRPI0617655A2 (pt) composto ou um sal farmaceuticamente aceitável do mesmo, ou um isômero óptico do mesmo, uso de um composto, e, formulação farmacêutica
EA200501697A1 (ru) Дозируемая форма, содержащая пантопразол в качестве активного ингредиента
TW200503785A (en) Dosage form containing (S)-pantoprazole as active ingredient
DK1666473T3 (da) Carboxylsyreforbindelser og medicinske sammensætninger indeholdende samme som aktiv ingrediens
NO20054319L (no) Neovaskulaseringspromoter
NO20023111L (no) Utvortes preparat for behandling av pruritus
NO20064808L (no) Orale matrixformuleringer med licarbazepin
UY27910A1 (es) Uso de un derivado de amina cíclica específico o de sus sales farmacéuticamente aceptables para tratar o prevenir la insuficiencia cardiaca
AR057885A1 (es) Acido 1-(1-(2- etoxietil) - 1- etil-7-(4- metilpiridin -2- ilamino)- 1h pirazolo (4,3-d) pirimidin -5- il) piperidina -4- carboxilico y las sales del mismo. composiciones farmaceuticas.
NO20052125L (no) Utvortes preparat for inhibering av keloiddannelse
NO20064196L (no) Utvortes preparat for behandling av smertefulle hudskader
UY27920A1 (es) Combinaciones de epinastina, pseudoefedrina y metilefedrina como nuevas formulaciones farmaceuticas

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application